Outcomes and Adverse Events Among Patients with Vancomycin-Resistant Enterococcal Bloodstream Infection Treated with Daptomycin Doses Greater than 12 mg/kg. [PDF]
Lin LW +7 more
europepmc +1 more source
Commonly prescribed medicines antagonise anti-MRSA antibiotics and select for resistance. [PDF]
Sohail Z +3 more
europepmc +1 more source
Patient with portal vein thrombosis and suppurative pylephlebitis presenting with multiple liver abscesses: a case report. [PDF]
Ay M +4 more
europepmc +1 more source
Daptomycin and linezolid salvage therapy for persistent ampicillin-susceptible <i>Enterococcus faecalis</i> bacteremia in a patient with possible anaphylaxis to β-lactam and glycopeptide antimicrobials: A case report. [PDF]
Phuong N +6 more
europepmc +1 more source
Daptomycin failure in the treatment of Enterococcus faecium bacteremia: microbiological insights and the importance of dual therapy including beta-lactam. [PDF]
Luque Paz D, Tattevin P.
europepmc +1 more source
Costs Associated with Failure of Vancomycin Treatment for Pneumonia and Bacteremia Due to Methicillin-Resistant <i>Staphylococcus aureus</i>. [PDF]
Josey M +5 more
europepmc +1 more source
Vancomycin-variable enterococci as a silent reservoir of resistance: characterization of the first reported vancomycin-variable <i>Enterococcus faecium</i> isolate in Switzerland. [PDF]
Cherkaoui A +6 more
europepmc +1 more source
Revealing the Fate of Isomeric Monounsaturated Fatty Acids in <i>Enterococcus faecalis</i> Membrane Lipids and Their Influence on Antimicrobial Susceptibility. [PDF]
Casey RL +3 more
europepmc +1 more source
Ceftaroline for Methicillin-Resistant Staphylococcus aureus Endovascular Infection. [PDF]
Cosimi RA +5 more
europepmc +1 more source
<i>Staphylococcus pettenkoferi</i>: an underrecognized species with clinically relevant antimicrobial resistance. A comprehensive genomic European study. [PDF]
Magnan C +16 more
europepmc +1 more source

